F5 Inc vs Zimmer Biomet Holdings Inc — how do they compare? F5 Inc trades at $414 (market cap $23.44B), while Zimmer Biomet Holdings Inc trades at $97 (market cap $18.55B). The key difference: F5 Inc is the larger of the two by market cap, and Zimmer Biomet Holdings Inc pays a 0.99% dividend while F5 Inc pays none. Which is the better fit depends on your goals.
| FFIV | ZBH | |
|---|---|---|
Market Cap | $23.44B | $18.55B |
Sector | Technology | Health |
52-Week High | $431.26 | $107.71 |
52-Week Low | $223.99 | $79.58 |
Enterprise Value | $22.08B | $25.61B |
Dividend Yield | — | 0.99% |
Trailing returns across standard periods
F5 is a market leader in the application delivery controller market. The company sells products for networking traffic, security, and policy management. Its products ensure applications are safely routed in efficient manners within on-premises data centers and across cloud environments. More than half of its revenue is based on providing services, and its three customer verticals are enterprises, service providers, and government entities. The Seattle-based firm was incorporated in 1996 and generates sales globally.
Read more on FFIV →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →